poster

An Unexpected Major Circulating Metabolite M219 Detected in 14C-labeled Human ADME Study of  Brilaroxazine

At Frontage Laboratories, a systematic method development approach has been established by continuous monitoring of radioactivity at different study stages, such as in-life mass balance, sample extraction, and column recovery.